1. Does a specific venous thromboembolism protocol exist for your Trust?
If so:
2. What date was this protocol put into place?
3. When is it due for review?
4. Is there a preferred Direct Oral Anticoagulant (DOAC) or are all utilised within the trust for VTE
5. How many patients have been treated for VTE with a DOAC in the last 12 months?
6. What volume of each DOAC was used to Treat VTE in this same time period?
